OncoCyte Corporation, a subsidiary of BioTime, Inc. (NYSE MKT: BTX), today announced that Chief Executive Officer Joseph Wagner, Ph.D. is scheduled to present at the inaugural BTIG Emerging Technologies in Healthcare Diagnostics Symposium being held September 29-30, 2014 at The Benjamin Hotel in New York City. As part of the symposium, leading diagnostic companies will present on a series of thematic panels to familiarize attendees with the diagnostic space, associated technologies, and foster an understanding of how the tools work and why they should be adopted. Participants in the conference include publicly-traded companies as well as companies that, like OncoCyte, are not yet publicly traded.
Help employers find you! Check out all the jobs and post your resume.
